1. ZHAW digitalcollection
  2. Life Sciences und Facility Management
  3. Publikationen
  4. Publikationen Life Sciences und Facility Management
Please use this identifier to cite or link to this item: https://doi.org/10.21256/zhaw-26688
Full metadata record
DC FieldValueLanguage
dc.contributor.authorFischer, Thomas-
dc.contributor.authorRiedl, Rainer-
dc.date.accessioned2023-01-23T10:02:35Z-
dc.date.available2023-01-23T10:02:35Z-
dc.date.issued2022-02-
dc.identifier.issn1359-6446de_CH
dc.identifier.issn1878-5832de_CH
dc.identifier.urihttps://digitalcollection.zhaw.ch/handle/11475/26688-
dc.description.abstractGiven the vast number of venomous and poisonous animals, it is surprising that only relatively few animal-derived toxins have been explored and made their way into marketed drugs or are being investigated in ongoing clinical trials. In this review, we highlight marketed drugs deriving from animal toxins as well as ongoing clinical trials and preclinical investigations in the field. We emphasize that more attention should be paid to the rich supply of candidates that nature provides as valuable starting points for addressing serious unmet medical needs.de_CH
dc.language.isoende_CH
dc.publisherElsevierde_CH
dc.relation.ispartofDrug Discovery Todayde_CH
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/4.0/de_CH
dc.subjectAnimal toxinde_CH
dc.subjectDrug discoveryde_CH
dc.subjectMedicinal chemistryde_CH
dc.subjectNatural productde_CH
dc.subjectPeptidede_CH
dc.subjectVenomde_CH
dc.subjectAnimalde_CH
dc.subjectToxin, biologicalde_CH
dc.subjectVenomde_CH
dc.subject.ddc615: Pharmakologie und Therapeutikde_CH
dc.titleParacelsus' legacy in the faunal realm : drugs deriving from animal toxinsde_CH
dc.typeBeitrag in wissenschaftlicher Zeitschriftde_CH
dcterms.typeTextde_CH
zhaw.departementLife Sciences und Facility Managementde_CH
zhaw.organisationalunitInstitut für Chemie und Biotechnologie (ICBT)de_CH
dc.identifier.doi10.1016/j.drudis.2021.10.003de_CH
dc.identifier.doi10.21256/zhaw-26688-
dc.identifier.pmid34678490de_CH
zhaw.funding.euNode_CH
zhaw.issue2de_CH
zhaw.originated.zhawYesde_CH
zhaw.pages.end575de_CH
zhaw.pages.start567de_CH
zhaw.publication.statuspublishedVersionde_CH
zhaw.volume27de_CH
zhaw.publication.reviewPeer review (Publikation)de_CH
zhaw.webfeedOrganische Chemiede_CH
zhaw.webfeedCC Drug Discoveryde_CH
zhaw.author.additionalNode_CH
zhaw.display.portraitYesde_CH
Appears in collections:Publikationen Life Sciences und Facility Management

Files in This Item:
File Description SizeFormat 
2022_Fischer-Riedl_Paracelsus-legacy-in-the-faunal-realm_DDT.pdf754.25 kBAdobe PDFThumbnail
View/Open
Show simple item record
Fischer, T., & Riedl, R. (2022). Paracelsus’ legacy in the faunal realm : drugs deriving from animal toxins. Drug Discovery Today, 27(2), 567–575. https://doi.org/10.1016/j.drudis.2021.10.003
Fischer, T. and Riedl, R. (2022) ‘Paracelsus” legacy in the faunal realm : drugs deriving from animal toxins’, Drug Discovery Today, 27(2), pp. 567–575. Available at: https://doi.org/10.1016/j.drudis.2021.10.003.
T. Fischer and R. Riedl, “Paracelsus’ legacy in the faunal realm : drugs deriving from animal toxins,” Drug Discovery Today, vol. 27, no. 2, pp. 567–575, Feb. 2022, doi: 10.1016/j.drudis.2021.10.003.
FISCHER, Thomas und Rainer RIEDL, 2022. Paracelsus‘ legacy in the faunal realm : drugs deriving from animal toxins. Drug Discovery Today. Februar 2022. Bd. 27, Nr. 2, S. 567–575. DOI 10.1016/j.drudis.2021.10.003
Fischer, Thomas, and Rainer Riedl. 2022. “Paracelsus’ Legacy in the Faunal Realm : Drugs Deriving from Animal Toxins.” Drug Discovery Today 27 (2): 567–75. https://doi.org/10.1016/j.drudis.2021.10.003.
Fischer, Thomas, and Rainer Riedl. “Paracelsus’ Legacy in the Faunal Realm : Drugs Deriving from Animal Toxins.” Drug Discovery Today, vol. 27, no. 2, Feb. 2022, pp. 567–75, https://doi.org/10.1016/j.drudis.2021.10.003.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.